Fate Therapeutics Inc (FATE) may enjoy gains as insiders got busy in the recent days
In a filing, Fate Therapeutics Inc revealed its Chief Financial Officer Dulac Edward J III unloaded Company’s shares for reported $19013.0 on Mar 04 ’24. In the deal valued at $7.77 per share,2,447 shares were sold. As a result of this transaction, Dulac Edward J III now holds 101,479 shares worth roughly $0.7 million. Then, […]
Fate Therapeutics Inc [FATE] Stock sold by Insider Dulac Edward J III for $19013.0
Fate Therapeutics Inc’s filing revealed that its Chief Financial Officer Dulac Edward J III unloaded Company’s shares for reported $19013.0 on Mar 04 ’24. In the deal valued at $7.77 per share,2,447 shares were sold. As a result of this transaction, Dulac Edward J III now holds 101,479 shares worth roughly $0.71 million. Then, Dulac […]
Fate Therapeutics Inc (FATE) receives an Equal weight rating from Wells Fargo
In a filing, Fate Therapeutics Inc revealed its Chief Financial Officer Dulac Edward J III unloaded Company’s shares for reported $19013.0 on Mar 04 ’24. In the deal valued at $7.77 per share,2,447 shares were sold. As a result of this transaction, Dulac Edward J III now holds 101,479 shares worth roughly $0.78 million. Then, […]
FATE stock rated an Equal weight by Wells Fargo
Fate Therapeutics Inc’s recent filing unveils that its Chief Financial Officer Dulac Edward J III unloaded Company’s shares for reported $19013.0 on Mar 04. In the deal valued at $7.77 per share,2,447 shares were sold. As a result of this transaction, Dulac Edward J III now holds 101,479 shares worth roughly $0.7 million. Then, Dulac […]
Fate Therapeutics Inc [FATE] stock for 9,245 USD was sold by Dulac Edward J III
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Fate Therapeutics Inc shares valued at $9,245 were sold by Dulac Edward J III on Jan 29. At $5.00 per share, Dulac Edward J III sold 1,849 shares. The insider’s holdings […]
Monitoring Fate Therapeutics Inc (FATE) after recent insider movements
Fate Therapeutics Inc’s filing revealed that its Chief Financial Officer Dulac Edward J III unloaded Company’s shares for reported $9245.0 on Jan 29. In the deal valued at $5.00 per share,1,849 shares were sold. As a result of this transaction, Dulac Edward J III now holds 103,926 shares worth roughly $0.72 million. Then, Wolchko J […]
Is it a good time to sell Fate Therapeutics Inc [FATE] shares after an insider sold 1,849 shares?
Fate Therapeutics Inc’s recent filing unveils that its Chief Financial Officer Dulac Edward J III unloaded Company’s shares for reported $9245.0 on Jan 29. In the deal valued at $5.00 per share,1,849 shares were sold. As a result of this transaction, Dulac Edward J III now holds 103,926 shares worth roughly $0.73 million. Then, Wolchko […]
Days-to-cover ratio for FATE surges to 3.65 due to rise in short interest
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Fate Therapeutics Inc shares valued at $9,245 were sold by Dulac Edward J III on Jan 29. At $5.00 per share, Dulac Edward J III sold 1,849 shares. The insider’s holdings […]
Fate Therapeutics Inc [FATE] Insider Dulac Edward J III sells 1,849 Shares
Fate Therapeutics Inc’s recently made public that its Chief Financial Officer Dulac Edward J III unloaded Company’s shares for reported $9245.0 on Jan 29. In the deal valued at $5.00 per share,1,849 shares were sold. As a result of this transaction, Dulac Edward J III now holds 103,926 shares worth roughly $0.65 million. Then, Wolchko […]